November 14, 2017
Experts estimate that about 50% of the people living with MS are impacted by depression. And left untreated, depression can darken your entire outlook on the world. It has a way of making everything less. We're going to explore MS and depression with my guest, Dr. Amy Sullivan, Director of Behavioral Medicine at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic.
Experts estimate that about 50% of the people living with MS are impacted by depression. And left untreated, depression can darken your entire outlook on the world. It has a way of making everything less. We're going to explore MS and depression with my guest, Dr. Amy Sullivan, Director of Behavioral Medicine at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic.
We're also talking about a study that may offer some good news about what seems to be a highly effective drug therapy for the 10,000 children who have been diagnosed with MS. We'll look at a nationwide study that indicates that women who are diagnosed with MS are reluctant to talk with their doctors about how MS might affect their work lives, their family planning choices, and even their personal relationships. And we'll look at the pending European Union approval of Ocrevus as a treatment for both Relapsing Remitting and Primary Progressive MS.
We've got the latest news, views, interviews & breakthroughs that are important to you. So…are you ready for RealTalk MS?